PE-conjugated Anti-IL31RA(nemolizumab biosimilar) mAb

PE-conjugated Anti-IL31RA(nemolizumab biosimilar) mAb
Artikelnummer
DMABME100231P-100
Verpackungseinheit
100 test
Hersteller
DIMA Biotechnology

Verfügbarkeit: wird geladen...
Preis wird geladen...
Background: Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.

Description: PE-conjugated Anti-IL31RA(nemolizumab biosimilar) mAb

Storage & Shipping: Store at 2°C-8°C fo 6 months

Formulation & Reconstitution: Liquid,PBS with 0.05% Proclin300, 404% BSA

Target: IL31RA

Uniprot ID: Q8NI17

Usage: Research use only

Recommended Dilutions: Flow Cyt 1:100

Common Name: CIM 331,CIM331

Guarantee: 6 months from date of dispatch
Mehr Informationen
Artikelnummer DMABME100231P-100
Hersteller DIMA Biotechnology
Hersteller Artikelnummer BME100231P-100
Verpackungseinheit 100 test
Mengeneinheit STK
Reaktivität Human
Methode Flow Cytometry
Isotyp C102S, E20G, H147Q, IgG2(C14S, Q298E), R16K, R234Q, S21G, S257A
Wirt Human
Konjugat Conjugated, PE (Phycoerythrin)
Produktinformation (PDF) Download
MSDS (PDF) Download